These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15232520)

  • 41. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunogenetic studies on systemic lupus erythematosus.
    Sebastiani GD; Galeazzi M
    Lupus; 2009 Sep; 18(10):878-83. PubMed ID: 19671786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group.
    Gómez-Puerta JA; Pons-Estel GJ; Quintana R; Nieto R; Serrano Morales RM; Harvey GB; Wojdyla D; Scolnik M; Funes Soaje C; Alba Moreyra P; Novatti E; Arizpe F; Berbotto GA; González Lucero L; Porta S; Pérez N; Rodriguez AM; Appenzeller S; de Oliveira E Silva Montadon AC; Monticielo OA; Cavalcanti FS; Machado Ribeiro F; Borba EF; Torres Dos Reis-Neto E; Neira O; Chahuán JM; Mimica M; Aroca Martínez G; Tobón GJ; Vásquez G; Quintana-Lopez G; Moreno Alvarez MJ; Saavedra MÁ; Cristobal MP; Fragoso-Loyo H; Amezcua-Guerra LM; González-Bello YC; Abud-Mendoza C; Esquivel-Valerio JA; Duarte M; Acosta Colman I; Mora-Trujillo C; Reátegui-Sokolova C; Calvo Quiroz AA; Muñoz-Louis R; Cairoli E; Rosas I; Rebella M; Cardiel MH; García de la Torre I; Catoggio LJ; Alarcón GS; Pons-Estel BA
    Lupus; 2021 Jan; ():961203320988586. PubMed ID: 33509067
    [No Abstract]   [Full Text] [Related]  

  • 44. Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus.
    Borchers AT; Keen CL; Shoenfeld Y; Gershwin ME
    Autoimmun Rev; 2004 Aug; 3(6):423-53. PubMed ID: 15351310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The history of antimalarials.
    Wallace DJ
    Lupus; 1996 Jun; 5 Suppl 1():S2-3. PubMed ID: 8803902
    [No Abstract]   [Full Text] [Related]  

  • 46. Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus.
    Qing X; Putterman C
    Autoimmun Rev; 2004 Nov; 3(7-8):505-9. PubMed ID: 15546798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A; Cheung BM; Mok CC; Leung R; Lau CS
    Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. B-cell-directed therapies in systemic lupus erythematosus.
    Tieng AT; Peeva E
    Semin Arthritis Rheum; 2008 Dec; 38(3):218-27. PubMed ID: 18206214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ergonomics in Latin America: background, trends and challenges.
    Soares MM
    Appl Ergon; 2006 Jul; 37(4):555-61. PubMed ID: 16756934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic lupus erythematosus.
    Manson JJ; Rahman A
    Orphanet J Rare Dis; 2006 Mar; 1():6. PubMed ID: 16722594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic lupus erythematosus in males. A study of 107 Latin American patients.
    Molina JF; Drenkard C; Molina J; Cardiel MH; Uribe O; Anaya JM; Gomez LJ; Felipe O; Ramirez LA; Alarcon-Segovia D
    Medicine (Baltimore); 1996 May; 75(3):124-30. PubMed ID: 8965681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S; Li LM; Costallat LT; Cendes F
    Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
    Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
    Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Some historical aspects of skin disease in lupus erythematosus.
    Rowell NR
    Lupus; 1997; 6(2):76-83. PubMed ID: 9061655
    [No Abstract]   [Full Text] [Related]  

  • 58. Lupus erythematosus. Historical perspectives.
    Callen JP
    Clin Dermatol; 1985; 3(3):1-3. PubMed ID: 3916825
    [No Abstract]   [Full Text] [Related]  

  • 59. [Toward a social history of Latin American dentistry].
    Canelon JS
    Acta Odontol Venez; 1982; 20(1):55-63. PubMed ID: 6764992
    [No Abstract]   [Full Text] [Related]  

  • 60. [The 60th anniversary of the discovery of the LE (lupus erythematosus) cell].
    Vachtenheim J
    Vnitr Lek; 2008 Jun; 54(6):672-3. PubMed ID: 18672581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.